Chanda Sanjay
Chief Development Officer at ANTX; SVP, Drug Development at Anacor Pharmaceuticals Inc
- Sold, on record
- $656k
- Dollars the filings state
- Form 4 sales
- 5
- Latest Jan 6, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- ANTXAN2 Therapeutics, Inc.Chief Development Officer
- Anacor Pharmaceuticals IncSVP, Drug Development
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Anacor Pharmaceuticals Inc20,000 shares
- ANTX12,208 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Anacor Pharmaceuticals IncUnusualSep 10, 2014 2014
Sold 10,000 shares at $24.25 ($243k)
Chanda Sanjay, SVP, Drug Development
Sold 71.5% of holdings ($339k position)3,995 shares leftFirst sale on recordFiling
- 2 Form 4 sale Anacor Pharmaceuticals IncUnusualNov 26, 2014 +77 days
Sold 5,000 shares at $35.00 ($175k)
Chanda Sanjay, SVP, Drug Development
Sold 55.6% of holdings ($315k position)3,995 shares leftFiling
- 3 Form 4 sale Anacor Pharmaceuticals IncPlan not statedMar 4, 2015 +98 days
Sold 5,000 shares at $45.00 ($225k)
Chanda Sanjay, SVP, Drug Development
Sold 14.7% of holdings ($1.5M position)29,087 shares leftFiling
- 4 Form 4 sale ANTXNo planJan 3, 2025 +3593 days
Sold 2,957 shares at $1.34 ($4k)
Chanda Sanjay, Chief Development Officer
No 10b5-1 planSold 9% of holdings ($44k position)29,824 shares leftFirst sale on recordFiling
- 5 Form 4 sale ANTXNo planJan 6, 2026 +368 days
Sold 9,251 shares at $1.01 ($9k)
Chanda Sanjay, Chief Development Officer
No 10b5-1 planSold 10.9% of holdings ($86k position)75,823 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | Jan 7, 2026 | ANTX | Chief Development Officer | Form 4 sale | 9,251 | $9k | 10.9% | No plan | SEC |
| Jan 3, 2025 | Jan 7, 2025 | ANTX | Chief Development Officer | Form 4 sale | 2,957 | $4k | 9.0% | No plan | SEC |
| Mar 4, 2015 | Mar 4, 2015 | Anacor Pharmaceuticals Inc | SVP, Drug Development | Form 4 sale | 5,000 | $225k | 14.7% | Plan not stated | SEC |
| Nov 26, 2014 | Dec 1, 2014 | Anacor Pharmaceuticals Inc | SVP, Drug Development | Form 4 sale | 5,000 | $175k | 55.6% | Unusual | SEC |
| Sep 10, 2014 | Sep 12, 2014 | Anacor Pharmaceuticals Inc | SVP, Drug Development | Form 4 sale | 10,000 | $243k | 71.5% | Unusual | SEC |